Journal of Stroke & Cerebrovascular Diseases
Volume 16, Issue 4 , Pages 160-166 , July 2007

Association of Apolipoprotein E Gene Polymorphism With Ischemic Stroke Involving Large-Vessel Disease and Its Relation to Serum Lipid Levels

  • Sarra Saidi, MSc

      Affiliations

    • Research Unit of Hematologic and Autoimmune Diseases, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia
    • ,
  • Lamia B. Slamia, MD

      Affiliations

    • Department of Neurology, Sahloul University Hospital Center, Sousse, Tunisia
    • ,
  • Sofyan B. Ammou, MD

      Affiliations

    • Department of Neurology, Sahloul University Hospital Center, Sousse, Tunisia
    • ,
  • Touhami Mahjoub, PhD

      Affiliations

    • Research Unit of Hematologic and Autoimmune Diseases, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia
    • ,
  • Wassim Y. Almawi, PhD

      Affiliations

    • College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain.
    • Corresponding Author InformationAddress reprint requests to Wassim Y. Almawi, PhD, Department of Medical Biochemistry, College of Medicine and Medical Sciences, Arabian Gulf University, PO Box 22979, Manama, Bahrain.

Received 11 January 2007 ,Accepted 14 March 2007.

References 

  1. Gao X, Yang H, Zhiping T. Association studies of genetic polymorphism, environmental factors and their interaction in ischemic stroke. Neurosci Lett. 2006;398:172–177
  2. Pezzini A, Grassi M, Del Zotto E, et al. Synergistic effect of apolipoprotein E polymorphisms and cigarette smoking on risk of ischemic stroke in young adults. Stroke. 2004;35:438–442
  3. Szolnoki Z, Melegh B. Gene–gene and gene–environment interplay represent specific susceptibility for different types of ischaemic stroke and leukoaraiosis. Curr Med Chem. 2006;13:1627–1634
  4. Liao D, Myers R, Hunt S, et al. Familial history of stroke and stroke risk: The Family Heart Study. Stroke. 1997;28:1908–1912
  5. Morgan L, Humphries SE. The genetics of stroke. Curr Opin Lipidol. 2005;16:193–199
  6. Siest G, Pillot T, Regis-Bailly A, et al. Apolipoprotein E: An important gene and protein to follow in laboratory medicine. Clin Chem. 1995;41:1068–1086
  7. Yamauchi K, Tozuka M, Nakabayashi T, et al. Apolipoprotein E in cerebrospinal fluid: Relation to phenotype and plasma apolipoprotein E concentrations. Clin Chem. 1999;45:497–504
  8. Luc G, Bard JM, Arveiler D, et al. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction (The ECTIM Study). Arterioscler Thromb. 1994;14:1412–1419
  9. Guz G, Nurhan Ozdemir F, Sezer S, et al. Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients. Am J Kidney Dis. 2000;36:826–836
  10. Corbo RM, Vilardo T, Mantuano E, et al. Apolipoproteins B and E, and angiotensin I-converting enzyme (ACE) genetic polymorphisms in Italian women with coronary artery disease (CAD) and their relationships with plasma lipid and apolipoprotein levels. Clin Genet. 1997;52:77–82
  11. Karpe F, Steiner G, Uffelman K, et al. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis. 1994;106:83–97
  12. Ohira T, Shahar E, Chambless LE, et al. Risk factors for ischemic stroke subtypes: The Atherosclerosis Risk in Communities Study. Stroke. 2006;37:2493–2498
  13. Tanne D, Koren-Morag N, Graff E, et al. Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: High triglycerides constitute an independent risk factor. Circulation. 2001;104:2892–2897
  14. Jurgens G, Taddei-Peters WC, Koltringer P, et al. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease. Stroke. 1995;26:1841–1848
  15. Sacco RL, Benson RT, Kargman DE, et al. High-density lipoprotein cholesterol and ischemic stroke in the elderly: The Northern Manhattan Stroke Study. JAMA. 2001;285:2729–2735
  16. Tanizaki Y, Kiyohara Y, Kato I, et al. Incidence and risk factors for subtypes of cerebral infarction in a general population: The Hisayama Study. Stroke. 2000;31:2616–2622
  17. Casas JP, Hingorani AD, Bautista LE, et al. Meta-analysis of genetic studies in ischemic stroke. Arch Neurol. 2004;61:1652–1662
  18. Sudlow C, Martinez Gonzalez NA, Kim J, et al. Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? (Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls). Stroke. 2006;37:364–370
  19. Souza DR, Campos BF, Arruda EF, et al. Influence of the polymorphism of apolipoprotein E in cerebral vascular disease. Arq Neuropsiquiatr. 2003;61:7–13
  20. Sturgeon JD, Folsom AR, Bray MS, et al. Atherosclerosis Risk in Communities Study Investigators (Apolipoprotein E genotype and incident ischemic stroke: The Atherosclerosis Risk in Communities Study). Stroke. 2005;36:2484–2486
  21. Mrabet A, Attia-Romdhane N, Ben Hamida M, et al. Epidemiologic aspects of cerebrovascular accidents in Tunisia. Rev Neurol. 1990;146:297–301(Paris)
  22. Aalto-Setala K, Palomaki H, Miettinen H, et al. Genetic risk factors and ischemic cerebrovascular disease: Role of common variation of the genes encoding apolipoproteins and angiotensin-converting enzyme. Ann Med. 1998;30:224–233
  23. Margaglione M, Seripa D, Gravina C, et al. Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: An Italian case-control study. Stroke. 1998;29:399–403
  24. Chikosi AB, Moodley J, Pegoraro RJ, et al. Apolipoprotein E polymorphism in South African Zulu women with preeclampsia. Hypertens Pregnancy. 2000;19:309–314
  25. Sandholzer C, Delport R, Vermaak H, et al. High frequency of the apo epsilon 4 allele in Khoi San from South Africa. Hum Genet. 1995;95:46–48
  26. Hilkevich O, Chapman J, Bone BS, et al. Prevalence of APO e4 allele in Israeli ethnic groups. Harefuah. 1999;136:845–847
  27. Osuntokun BO, Sahota A, Ogunniyi AO, et al. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer’s disease in elderly Nigerians. Ann Neurol. 1995;38:463–465
  28. Al-Khedhairy AA. Apolipoprotein E polymorphism in Saudis. Mol Biol Rep. 2004;31:257–260
  29. Mahfouz RA, Sabbagh AS, Zahed LF, et al. Apolipoprotein E gene polymorphism and allele frequencies in the Lebanese population. Mol Biol Rep. 2006;33:145–149
  30. Al-Bustan SA, Alnaqeeb MA, Annice BG, et al. Apolipoprotein E genotyping among the healthy Kuwaiti population. Hum Biol. 2005;77:487–498
  31. Lahlali-Kacemi N, Bamou Y, Guedira A, et al. Polymorphisme de l’apolipoprotéine E dans une population marocaine: Fréquence allélique et relation avec les paramètres lipidiques plasmatiques. Ann Biol Clin. 2002;60:73–78
  32. Woo D, Kaushal R, Chakraborty R, et al. Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage. Stroke. 2005;36:1874–1879
  33. Shahar E, Chambless LE, Rosamond WD, et al. Plasma lipid profile and incident ischemic stroke: ARIC. Stroke. 2003;34:623–631
  34. Neaton JD, Blackburn H, Jacobs D, et al. Multiple Risk Factor Intervention Trial Research Group Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med. 1992;152:1490–1500
  35. Muros M, Rodriguez-Ferrer C. Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4. Atherosclerosis. 1996;121:13–21
  36. Baumgartner RW, Sidler C, Mosso M, et al. Ischemic lacunar stroke in patients with and without potential mechanisms other than small-artery disease. Stroke. 2003;34:653–659
  37. Cerrato P, Imperiale D, Fornengo P, et al. Higher lipoprotein (a) levels in atherothrombotic than lacunar ischemic Cerebrovascular disease. Neurology. 2002;58:653–655
  38. Kessler C, Spitzer C, Stauske D, et al. The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol. 1997;17:2880–2884
  39. McCarron MO, Delong D, Alberts MJ. ApoE genotype as a risk factor for ischemic cerebrovascular disease: A meta-analysis. Neurology. 1999;43:1308–1311
  40. Kokubo Y, Chowdhury AH, Date C, et al. Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke. 2000;31:1299–1306
  41. Cerrato P, Baima C, Grasso M, et al. Apolipoprotein E polymorphism and stroke subtypes in an Italian cohort. Cerebrovasc Dis. 2005;20:264–269
  42. Banerjee I, Gupta V, Ganesh S. Association of gene polymorphism with genetic susceptibility to stroke in Asian populations: A meta-analysis. J Hum Genet. 2007;52:205–219

PII: S1052-3057(07)00037-7

doi: 10.1016/j.jstrokecerebrovasdis.2007.03.001

Journal of Stroke & Cerebrovascular Diseases
Volume 16, Issue 4 , Pages 160-166 , July 2007

Article Tools